HOME > 業績集 > Inhibition of MCP-1/CCR2 Signaling Pathway is Involved in Synergistic Inhibitory Effects of Irbesartan with Rosuvastatin on Vascular Remodeling.

Inhibition of MCP-1/CCR2 Signaling Pathway is Involved in Synergistic Inhibitory Effects of Irbesartan with Rosuvastatin on Vascular Remodeling.

2012年10月01日